Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2025-12-25 @ 7:24 PM
NCT ID:
NCT01777932
Group ID:
EG000
Title:
Paclitaxel + Bevacizumab Arm
Description:
Participants received licensed dose regimens of bevacizumab (10 mg/kg every 2 weeks or 15 mg/kg every 3 weeks) until disease progression, or unacceptable toxicity (whichever occurred first), in accordance with the summary of product characteristics. Paclitaxel could be administered weekly or every 3 weeks according to the accepted oncology protocol.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
19
Serious Number At Risk:
220
Other Number Affected:
68
Other Number At Risk:
220
Study:
NCT01777932
Results Section:
NCT01777932
Adverse Events Module:
NCT01777932